Literature DB >> 19935680

Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us?

Deepak L Bhatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19935680     DOI: 10.1038/nrcardio.2009.192

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

Review 1.  Scientific and therapeutic advances in antiplatelet therapy.

Authors:  Deepak L Bhatt; Eric J Topol
Journal:  Nat Rev Drug Discov       Date:  2003-01       Impact factor: 84.694

2.  Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?

Authors:  Deepak L Bhatt
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

3.  Prasugrel in clinical practice.

Authors:  Deepak L Bhatt
Journal:  N Engl J Med       Date:  2009-07-15       Impact factor: 91.245

4.  Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?

Authors:  Deepak L Bhatt
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-03-25

5.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

9.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 10.  Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis.

Authors:  Anthony A Bavry; Deepak L Bhatt
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

  10 in total
  5 in total

Review 1.  The evolution of antiplatelet therapy in cardiovascular disease.

Authors:  Omair Yousuf; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2011-07-12       Impact factor: 32.419

Review 2.  Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.

Authors:  Glenn N Levine; Young-Hoon Jeong; Shinya Goto; Jeffrey L Anderson; Yong Huo; Jessica L Mega; Kathryn Taubert; Sidney C Smith
Journal:  Nat Rev Cardiol       Date:  2014-08-26       Impact factor: 32.419

Review 3.  Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.

Authors:  Kumaran Kolandaivelu; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2010-06-01       Impact factor: 32.419

Review 4.  Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?

Authors:  Nishank Jain; S Susan Hedayati; Ravindra Sarode; Subhash Banerjee; Robert F Reilly
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

5.  Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.

Authors:  Kade Birkeland; David Parra; Robert Rosenstein
Journal:  J Blood Med       Date:  2010-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.